Aicuris Anti-infect Drug Patent Portfolio

Aicuris Anti-infect's Family Patents


Family Patents





Clinical Trials

Recent Clinical Trials by Aicuris Anti-infect:

Title Lead Sponsor Collaborators Status Phases
Clinical Trials
Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects AiCuris Anti-infective Cures AG NA COMPLETED
(Jun 1, 2026)
PHASE3


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List